"Rocky Mountain Oncology offers world-class cancer care, giving patients hope for a better quality of life and successful clinical outcomes. Our oncology team has provided cancer care to the Wyoming community for more than 20 years."

During the past decade, Rocky Mountain Oncology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 121 clinical trials were completed, i.e. on average, 1344.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 42 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rocky Mountain Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 64 trials, followed by "SWOG Cancer Research Network" with 46 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "Gynecologic Oncology Group" with 7 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 92 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Oncology" are "Breast Cancer" (16 trials), "Lung Cancer" (12 trials), "Lymphoma" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials) and "Prostate Cancer" (6 trials). Many other conditions were trialed in "Rocky Mountain Oncology" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Oncology" are "Drug" (133 trials), "Other" (95 trials), "Biological" (59 trials), "Procedure" (18 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Quality-of-Life Assessment" (27 trials), "Bevacizumab" (19 trials), "Paclitaxel" (16 trials) and "placebo" (16 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Oncology" are 120 trials for "All" genders, 29 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Rocky Mountain Oncology". undefined are not yet recruiting, 1 are recruiting, 54 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 87 completed trials in Rocky Mountain Oncology, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Oncology, 7 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 73 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".